Array Biopharma (ARRY) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $6.97 -2.79%
Revenue Growth %: -12.3%
Financial Fact:
Interest income: 70K
Today's EPS Names:
CRMT, More
Revenue Growth %: -12.3%
Financial Fact:
Interest income: 70K
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Array Biopharma (NASDAQ: ARRY) reported Q3 EPS of ($0.17), $0.03 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $64.7 million versus the consensus estimate of $54.04 million.
For earnings history and earnings-related data on Array Biopharma (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Array Technologies (ARRY) PT Lowered to $10 at Jefferies, 'Playing Offense Amid Preferred Anxiety'
- RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
